ArticlePakistan journal of medical sciences2026
Application and advantages of induced sputum cytology with gradient concentrations of hypertonic saline in the diagnosis of chronic cough.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the application and advantages of induced sputum cytology with gradient concentrations of hypertonic saline in the diagnosis of chronic cough (CC). Methodology: This was a prospective study. A total of 180 patients with CC admitted to Baoding No.1 Central Hospital between January 2022 to November 2024 were selected, and 115 individuals undergoing physical examinations during the same period were selected as the control group. Induced sputum cytology with gradient concentrations of hypertonic saline was conducted for all subjects. Analyzed the success rate of sputum induction and compared the results of sputum cytology examination of patients with different etiologies and the diagnosis rate of each test item for different etiologies. Results: The success rate of sputum induction was 92.78%(167/180), and the incidence of adverse reactions during the induction was 9.44%(17/180) in the patients with CC. These adverse reactions were resolved spontaneously after the induction was terminated. In patients with successful sputum induction, etiology was definitely diagnosed in 93.41%(156/176) patients, including cough variant asthma (CVA) in 38/156 patients (24.36%), eosinophilic bronchitis (EB) in 14/156 patients (8.97%), upper airway cough syndrome (UACS) in 25/156 patients (16.03%), gastroesophageal reflux cough (GERC) in 16/156 patients (10.26%), and atopic cough (AC) in 63/156 patients (40.38%). The etiology was unknown in 11/167 patients (6.59%). Conclusion: The success rate of sputum induction is high and the etiology is comprehensively diagnosed in patients with CC when induced sputum cytology with gradient concentrations of hypertonic saline is used.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.